ISI International Strategy & Investment

Health Care

Mark Schoenebaum, MD
Mark Schoenebaum, MD

Senior Managing Director
Biotechnology & Pharmaceuticals/Major Analyst
Head of Health Care Research
ISI’s Health Care Team

L to R: Odysseas Kostas, Natasha Yeung,
John Scotti, Mark Schoenebaum,
Vlad Nikolenko, Salim Syed

Coverage Universe

ABBV

ACOR

AMGN

BIIB


BMY

CELG

GILD

LLY


MRK

PFE

UTHR

VRTX


ZTS

 

 

 

ISI’s Health Care Research Team, headed by Mark Schoenebaum, focuses on providing actionable investment ideas and proprietary research on Biotechnology, Pharmaceutical, and Specialty Pharmaceutical stocks.

Mark has been conducting research on biotechnology companies for more than 14 years. Mark and his team provide clients with an investment edge through “data tidbits” and “on-the-fly” analysis in response to breaking news. They also provide "deep-dive" analyses on clinical, financial, and market data.

The Health Care Research Team is available around the clock, conducts customized client projects, assists with corporate access, and accepts personal meetings.